Aspira Women's Health Statistics
Share Statistics
Aspira Women's Health has 16.67M shares outstanding. The number of shares has increased by 55.4% in one year.
| Shares Outstanding | 16.67M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 29.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 11.67M |
| Failed to Deliver (FTD) Shares | 438 |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 537.64K, so 3.23% of the outstanding shares have been sold short.
| Short Interest | 537.64K |
| Short % of Shares Out | 3.23% |
| Short % of Float | 4.68% |
| Short Ratio (days to cover) | 4.15 |
Valuation Ratios
The PE ratio is -2.26 and the forward PE ratio is -1.29.
| PE Ratio | -2.26 |
| Forward PE | -1.29 |
| PS Ratio | 4.12 |
| Forward PS | 0.6 |
| PB Ratio | -15.93 |
| P/FCF Ratio | -2.37 |
| PEG Ratio | n/a |
Enterprise Valuation
Aspira Women's Health Inc. has an Enterprise Value (EV) of 37.93M.
| EV / Earnings | -2.27 |
| EV / Sales | 4.14 |
| EV / EBITDA | -2.3 |
| EV / EBIT | -2.01 |
| EV / FCF | -2.38 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of -0.96.
| Current Ratio | 1.03 |
| Quick Ratio | 0.99 |
| Debt / Equity | -0.96 |
| Total Debt / Capitalization | -2.29K |
| Cash Flow / Debt | -7.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 7.06% and return on capital (ROIC) is -3871.05%.
| Return on Equity (ROE) | 7.06% |
| Return on Assets (ROA) | -2.67% |
| Return on Capital (ROIC) | -3871.05% |
| Revenue Per Employee | 143.03K |
| Profits Per Employee | -260.78K |
| Employee Count | 64 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 17.15 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -72.89% in the last 52 weeks. The beta is 1.44, so Aspira Women's Health 's price volatility has been higher than the market average.
| Beta | 1.44 |
| 52-Week Price Change | -72.89% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.78 |
| Relative Strength Index (RSI) | 36.35 |
| Average Volume (20 Days) | 93.28K |
Income Statement
In the last 12 months, Aspira Women's Health had revenue of $9.15M and earned -$16.69M in profits. Earnings per share was $-1.81.
| Revenue | 9.15M |
| Gross Profit | 5.26M |
| Operating Income | -18.85M |
| Net Income | -16.69M |
| EBITDA | -16.49M |
| EBIT | -18.85M |
| Earnings Per Share (EPS) | -1.81 |
Balance Sheet
The company has $2.60M in cash and $2.85M in debt, giving a net cash position of -$255.00K.
| Cash & Cash Equivalents | 2.60M |
| Total Debt | 2.85M |
| Net Cash | -255.00K |
| Retained Earnings | -518.30M |
| Total Assets | 4.76M |
| Working Capital | -1.35M |
Cash Flow
In the last 12 months, operating cash flow was -$15.89M and capital expenditures -$24.00K, giving a free cash flow of -$15.92M.
| Operating Cash Flow | -15.89M |
| Capital Expenditures | -24.00K |
| Free Cash Flow | -15.92M |
| FCF Per Share | -1.72 |
Margins
Gross margin is 57.48%, with operating and profit margins of -205.94% and -182.32%.
| Gross Margin | 57.48% |
| Operating Margin | -205.94% |
| Pretax Margin | -182.32% |
| Profit Margin | -182.32% |
| EBITDA Margin | -180.15% |
| EBIT Margin | -205.94% |
| FCF Margin | -173.89% |
Dividends & Yields
AWH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -244.59% |
| FCF Yield | -128.42% |
Analyst Forecast
The average price target for AWH is $4.4, which is 494.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.4 |
| Price Target Difference | 494.6% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on May 12, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | May 12, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -165.21 |
| Piotroski F-Score | 3 |